Ricki Louise Fairley

Insider Reports History

Location
Chicago, IL
Signature
/s/ Beth Hecht, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ricki Louise Fairley:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Director Common Stock 135,000 $257,850 $1.91 05 Jun 2024 Direct

Insider Reports Filed by Ricki Louise Fairley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 16:19
XERS Xeris Biopharma Holdings, Inc. 27 Mar 2023 1 $0 4 Director 29 Mar 2023, 16:53
XERS Xeris Biopharma Holdings, Inc. 27 Mar 2023 0 $0 3 Director 29 Mar 2023, 16:23